CRVO Financials CervoMed Inc.
15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $4M | -$27M | 0.0% | -706.2% | -148.0% | -117.9% | — | — | $8M |
| 2024 | $10M | -$16M | 0.0% | -187.2% | -41.6% | -37.8% | — | — | $9M |
| 2023 | $7M | -$2M | 0.0% | -109.3% | -29.4% | -21.8% | — | — | $8M |
| 2022 | $0 | -$6M | — | — | 17.4% | -139.6% | — | — | $4M |
| 2021 | — | -$24M | — | — | -69.0% | -63.7% | — | — | $37M |
| 2020 | — | -$14M | — | — | -57.2% | -51.2% | — | — | $19M |
| 2019 | — | -$12M | — | — | -58.6% | -48.9% | — | — | $14M |
| 2018 | — | -$18M | — | — | -117.7% | -100.9% | — | — | $8M |
| 2017 | — | -$1M | — | — | -6.4% | -5.2% | -$13M | — | $9M |
| 2016 | — | -$18M | — | — | -196.4% | -103.2% | -$11M | — | $2M |
| 2015 | — | -$7M | — | — | 16143.1% | -295.1% | -$5M | — | $2M |
| 2014 | — | -$14M | — | — | -37.6% | -33.6% | -$9M | — | $2M |
| 2013 | — | -$2M | — | — | -38.1% | -13.4% | — | — | $254964 |
| 2012 | $374542 | -$7M | 37.0% | -3148.3% | 37.4% | -280.8% | — | — | $312093 |
| 2011 | $570476 | -$23M | -304.7% | -2879.9% | 140.9% | -616.2% | — | — | $98449 |
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $0 | -$7M | — | — | -28.6% | -25.3% | — | — | $22M |
| Mar '26 | $0 | -$8M | — | — | -75.0% | -52.7% | — | — | $8M |
| Dec '25 | $8726 | -$8M | 0.0% | -95479.2% | -44.4% | -35.3% | — | — | $8M |
| Sep '25 | $322569 | -$8M | 0.0% | -2493.8% | -29.7% | -25.2% | — | — | $9M |
| Jun '25 | $2M | -$6M | 0.0% | -376.4% | -18.7% | -16.4% | — | — | $8M |
| Mar '25 | $2M | -$5M | 0.0% | -276.6% | -14.1% | -12.7% | — | — | $11M |
| Dec '24 | $2M | -$7M | 0.0% | -334.9% | -17.1% | -15.6% | — | — | $9M |
| Sep '24 | $2M | -$5M | 0.0% | -278.2% | -10.4% | -9.7% | — | — | $8M |
| Jun '24 | $3M | -$2M | 0.0% | -91.1% | -4.6% | -4.4% | — | — | $10M |
| Mar '24 | $2M | -$3M | 0.0% | -110.6% | -47.1% | -31.4% | — | — | $6M |
| Dec '23 | $2M | -$2M | 0.0% | -99.6% | -32.0% | -23.7% | — | — | $8M |
| Sep '23 | $2M | $2M | 0.0% | -175.2% | 22.5% | 17.9% | — | — | $10M |
| Jun '23 | $2M | -$1M | 0.0% | -71.6% | 4.1% | -42.4% | — | — | $15M |
| Mar '23 | $1M | -$534336 | 0.0% | -101.3% | 1.6% | -13.5% | — | — | $15M |
| Dec '22 | $0 | -$2M | — | — | 4.6% | -36.7% | — | — | $4M |
| Sep '22 | $0 | -$882623 | — | — | -3.7% | -3.4% | — | — | $7M |
| Jun '22 | — | -$4M | — | — | -15.7% | -14.4% | — | — | $6M |
| Mar '22 | — | -$5M | — | — | -14.8% | -13.5% | — | — | $10M |
| Dec '21 | — | -$3M | — | — | -10.0% | -9.2% | — | — | $37M |
| Sep '21 | — | -$12M | — | — | -32.0% | -29.8% | — | — | $40M |
Valuation over time
How the market has priced CRVO against its own fundamentals since 2023-08 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-sales ratio has fallen from 18.0× (Jan '24) to 5.8× (Nov '26).
Frequently asked questions
Is CRVO growing its revenue and profit?
See the revenue and net-income charts above for CervoMed Inc.'s multi-year trend.
How much debt does CRVO have?
As of FY2025, CervoMed Inc. reported — of total debt against $8M of cash.
What is CRVO's profit margin?
In FY2025, gross margin was —, operating margin -706.2%, and net margin -673.2%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.